343 related articles for article (PubMed ID: 9216657)
21. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
Cîmpean AM; Raica M; Nariţa D
Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
[TBL] [Abstract][Full Text] [Related]
24. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues].
Pierart J; Oñate E; Klaassen R; Cid L; Gutierrez S; Talbot E; Ross E; Zambrano C; Burmeister R; Puchi M
Rev Med Chil; 1995 Feb; 123(2):165-75. PubMed ID: 7569456
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
26. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
[TBL] [Abstract][Full Text] [Related]
27. Integrin expression on normal and neoplastic human breast epithelium.
Damjanovich L; Fülöp B; Adány R; Nemes Z
Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
[TBL] [Abstract][Full Text] [Related]
28. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Mylona EE; Alexandrou PT; Giannopoulou IA; Rafailidis PI; Markaki S; Keramopoulos A; Nakopoulou LL
Cancer Detect Prev; 2006; 30(2):111-7. PubMed ID: 16632244
[TBL] [Abstract][Full Text] [Related]
29. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
30. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
Tsuura Y; Suzuki T; Honma K; Sano M
J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
[TBL] [Abstract][Full Text] [Related]
31. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
32. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
33. B7-h4 is highly expressed in ductal and lobular breast cancer.
Tringler B; Zhuo S; Pilkington G; Torkko KC; Singh M; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Clin Cancer Res; 2005 Mar; 11(5):1842-8. PubMed ID: 15756008
[TBL] [Abstract][Full Text] [Related]
34. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
35. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
37. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
38. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
39. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
40. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
